logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Institute Paoli-Calmettes

+33491223333
service-dons@ipc.unicancer.fr
Source: Site record.
https://www.institutpaolicalmettes.fr

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Paoli-Calmettes Institute is entrusted by law with a public service mission in the field of cancer care.The Paoli-Calmettes Institute (IPC), particularly through its new institutional project, is firmly rooted in the core values shared by the comprehensive cancer centers of which it is a part:The pursuit of excellenceSolidarityHumanityInnovation in patient relationships

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Cancer treatment center

Business Subcategory

Source: Human-provided. Cancer treatment center
Source: Human-provided. Government hospital
Source: Human-provided. Hospital
Source: Human-provided. Research institute
Source: Trial-derived.
55Total Trials
Source: Trial-derived.
7Recruiting Trials
Source: Trial-derived.
23Active Trials
Source: Trial-derived.
26Completed Trials
Source: Trial-derived.
80Unique Conditions
Source: Trial-derived.
53Unique Sponsors

Conditions

Source: Trial-derived. Acute Myeloid Leukemia (4)Source: Trial-derived. Multiple Myeloma (3)Source: Trial-derived. Non Small Cell Lung Cancer Metastatic (3)Source: Trial-derived. Colorectal Cancer (2)Source: Trial-derived. Gestational Trophoblastic Neoplasias (GTN) (2)Source: Trial-derived. Metastatic Breast Cancer (2)Source: Trial-derived. Acute Lymphoblastic Leukemia (1)Source: Trial-derived. Acute Myeloblastic Leukemia (1)

Sponsors

Source: Trial-derived. Hospices Civils de Lyon (7)Source: Trial-derived. Intergroupe Francophone de Cancerologie Thoracique (4)Source: Trial-derived. Boehringer Ingelheim (3)Source: Trial-derived. Federation Francophone de Cancerologie Digestive (3)Source: Trial-derived. French Innovative Leukemia Organisation (3)Source: Trial-derived. Institut Paoli-Calmettes (3)Source: Trial-derived. Amgen (2)Source: Trial-derived. Bayer (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Echocardiography

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Circulating tumour DNA testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Proteomics

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom
Source: Google. Wheelchair accessible seating

Parking Options

Source: Google. Paid parking garage

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Local tumour mutation testing
Source: AI-inferred. Minimal residual disease testing
Source: AI-inferred. Ophthalmological examination
Source: AI-inferred. Visual acuity testing / ophthalmic safety assessment